<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Levels of the serum <z:chebi fb="0" ids="37670">protease inhibitors</z:chebi> (alpha 1-antichymotrypsin, alpha 1-antitrypsin, and inter-alpha-trypsin inhibitor) were measured in patients with senile <z:hpo ids='HP_0000726'>dementia</z:hpo> of the Alzheimer type (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SDAT</z:e>) to determine whether these levels might be useful as diagnostic markers of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SDAT</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The levels of alpha 1-antichymotrypsin were found to have no relationship to either age or sex </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SDAT</z:e> group showed levels of alpha 1-antichymotrypsin significantly higher than those of any of the following groups: <z:mpath ids='MPATH_458'>normal</z:mpath> control group (p less than 0.001), vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> group (p less than 0.01), mixed type <z:hpo ids='HP_0000726'>dementia</z:hpo> group (p less than 0.05), and 3 other groups (<z:e sem="disease" ids="C0030567" disease_type="Disease or Syndrome" abbrv="PD">Parkinson's disease</z:e>, <z:hpo ids='HP_0002503'>spinocerebellar degeneration</z:hpo>, cerebrovascular disease) (p less than 0.001) </plain></SENT>
<SENT sid="3" pm="."><plain>The serum concentration of alpha 1-antichymotrypsin seemed to increase slightly in advanced stages of the disease </plain></SENT>
<SENT sid="4" pm="."><plain>The serum levels of both alpha 1-antitrypsin and inter-alpha-trypsin inhibitor differed insignificantly in comparison of the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SDAT</z:e> group and <z:mpath ids='MPATH_458'>normal</z:mpath> control group </plain></SENT>
<SENT sid="5" pm="."><plain>Of the 3 serum <z:chebi fb="0" ids="37670">protease inhibitors</z:chebi> measured, only alpha 1-antichymotrypsin was found to increase significantly in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SDAT</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>These findings suggest that the measurement of serum concentration of alpha 1-antichymotrypsin may prove useful as a diagnostic marker of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SDAT</z:e> </plain></SENT>
</text></document>